RT Journal
A1 Richards ML, Bingener-Casey J, Pierce D, Strodel WE, Sirinek KR
T1 Intraoperative parathyroid hormone assay: An accurate predictor of symptomatic hypocalcemia following thyroidectomy
JF Archives of Surgery
JO Archives of Surgery
YR 2003
FD June 1
VO 138
IS 6
SP 632
OP 636
DO 10.1001/archsurg.138.6.632
UL http://dx.doi.org/10.1001/archsurg.138.6.632
AB Hypothesis 
    Intraoperative parathyroid hormone (IOPTH) assay is useful for predicting symptomatic hypocalcemia following total thyroidectomy.Design 
    A prospective study of 30 patients undergoing total thyroidectomy with IOPTH levels obtained following skin closure and ionized calcium (Ca2+) levels obtained 6 hours postoperatively and on postoperative day 1. All patients were evaluated for symptoms of hypocalcemia.Setting 
    University teaching hospital.Main Outcome Measures 
    Patients who developed symptomatic hypocalcemia were compared with asymptomatic patients in regard to age, diagnosis, thyroid weight, thyrotropin level, Ca2+ level, parathyroid status, and IOPTH level.Results 
    The onset of symptomatic hypocalcemia ranged from 8 to 48 hours postoperatively (n = 10). One patient required readmission. Of 10 patients with symptoms, 5 developed tetany. There were no significant differences in age, diagnosis, thyroid weight, thyrotropin level, or the number of parathyroid glands preserved in patients with or without symptomatic hypocalcemia. All patients with an IOPTH level of less than 10 pg/mL (1.1 pmol/L) had symptoms (n = 8). The mean ± SD IOPTH level (7.6 ± 12.0 pg/mL [0.8 ± 1.3 pmol/L]) in patients who developed symptomatic hypocalcemia was significantly lower than the mean IOPTH level (55.7 ± 31.8 pg/mL [5.9 ± 3.3 pmol/L]) in patients without symptoms (P = .001). The 6-hour and postoperative day 1 Ca2+ levels were significantly lower in patients with symptomatic hypocalcemia (P = .19 and = .13, respectively). An IOPTH level of less than 10 pg/mL is 80% sensitive and 100% specific for the development of symptomatic hypocalcemia.Conclusion 
    The incorporation of the IOPTH assay in the management of thyroid disease is recommended to prevent and prospectively treat symptomatic hypocalcemia, thereby reducing readmissions following thyroidectomy.